Home>Latest
- August 30, 2021
China's Zhejiang to build sea island parks
East China's Zhejiang province, which boasts the most sea islands among the country's provincial-level regions, is building some of its scenic islands into tourist draws in efforts to boost its tourism sector.
- August 27, 2021
China unveils regulation on market entity registration, administration
Chinese Premier Li Keqiang has signed a State Council decree unveiling a regulation on the registration and administration of market entities.
- August 27, 2021
CEEC commodities to be sold at gas station convenience stores
An online conference designed to boost the sales of goods from Central and Eastern European countries (CEEC) in domestic stores and supermarkets was held in Ningbo, East China's Zhejiang province on Aug 26.
- August 27, 2021
3 Ningbo areas recognized provincially for folk culture, art
Three areas in Ningbo, East China's Zhejiang province recently made the list of "Zhejiang Hometowns of Folk Culture and Art".
- August 27, 2021
Negative COVID test required for returning college faculty, students
Faculty and students of colleges and universities have to provide a negative COVID-19 test result within 48 hours before returning to school, according to a statement released on the website of the National Health Commission.
- August 26, 2021
Explosives expert Zheng Zhemin dies at 97
Zheng Zhemin, an academician of both the Chinese Academy of Sciences and the Chinese Academy of Engineering and a winner of the State Scientific and Technological Award, died of disease at 97 on Wednesday.
- August 26, 2021
Ningbo students to return to school in batches
Students in Ningbo, East China's Zhejiang province will return to their schools in batches to start the new semester in September, according to officials at a press conference held by the local epidemic prevention and control authorities on Aug 25.
- August 26, 2021
Ningbo aims high in biopharmaceutical industry
Ningbo in East China's Zhejiang province recently unveiled a five-year plan to develop its biopharmaceutical industry.